Two stocks at opposite ends of the spectrum are Amgen (NASDAQ: AMGN), the healthcare behemoth, and Viking Therapeutics ...

Getting enough protein while on a GLP-1 complements the appetite-suppressing effects of the medication. But how much is enough?

As the demand for GLP-1 drugs like Ozempic and Wegovy increases with consumers eager to shed pounds, the supplement industry ...

In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

A Senate hearing Tuesday will look at why the list prices of Ozempic and Wegovy are much higher in the U.S. than in ...

本文来自微信公众号：学术经纬 （ID：Global_Academia），作者：药明康德内容团队，原文标题：《再次摘得“诺奖风向标”，革命性减肥疗法的开发者能否问鼎诺奖？》题图来自：unsplash ...

According to the Journal, the GLP-1 "pricing fight" began in late 2023, when Lilly priced Zepbound at $1,060 per month, or 20% lower than Novo Nordisk's Wegovy. Analysts told the newspaper that prices ...

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

Amid expectations that the popularity of GLP-1 drugs will decrease bariatric surgery rates, a Cleveland Clinic-led study found these surgeries might be more effective than GLP-1s for some patients.

A few months ago, we looked into Ozempic face, a phenomenon that happens when a decrease in fat creates hollowness in the eyes, cheek area and temples, creating a more skeletal and aged appearance in ...

2014年，在领导GLP-1项目20年之后，时年50岁的克努森在丹麦哥本哈根大学成功通过了医学博士学位的论文答辩，博士论文的内容就是她关于利拉鲁肽的研究，克努森学术上的伙伴和引路人、GLP-1研究先驱、哥本哈根大学教授霍斯特（Jens Juul ...